NeoManna - Next Generation Insect-derived Antimicrobials
Agchimedes is a venture builder focused on creating and nurturing companies at the intersection of climate change and food security. Leveraging life science, data science, and AI, the company identifies unmet needs and develops innovative solutions. Agchimedes builds companies by identifying critical global challenges, harnessing cutting-edge technologies from the Israeli ecosystem, and providing strategic guidance for growth and scaling. Their core purpose is to found leading companies with a global impact, addressing pressing challenges to ensure food security and mitigate climate change for a sustainable future. Their portfolio includes NeoManna (antimicrobial solutions for animal health), Sustained Therapies (phage-based solutions for bacterial diseases), NetaGenomiX (plant genetics), and ReGEV Bio (regulating gene expression in plants).
NeoManna - Next Generation Insect-derived Antimicrobials
Agchimedes is a venture builder focused on creating and nurturing companies at the intersection of climate change and food security. Leveraging life science, data science, and AI, the company identifies unmet needs and develops innovative solutions. Agchimedes builds companies by identifying critical global challenges, harnessing cutting-edge technologies from the Israeli ecosystem, and providing strategic guidance for growth and scaling. Their core purpose is to found leading companies with a global impact, addressing pressing challenges to ensure food security and mitigate climate change for a sustainable future. Their portfolio includes NeoManna (antimicrobial solutions for animal health), Sustained Therapies (phage-based solutions for bacterial diseases), NetaGenomiX (plant genetics), and ReGEV Bio (regulating gene expression in plants).